ArticleTropical medicine and health2026
Burden of polycystic ovary syndrome in low-and middle-income countries, 1990-2023: results from the global burden of disease study 2023.
Article in Tropical medicine and health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPolycystic ovary syndrome (PCOS) is prevalent in low- and middle-income countries (LMICs), yet comprehensive assessments of its disease burden are lacking. This study aimed to evaluate the disease burden of PCOS in LMICs from 1990 to 2023.
methodsUsing Global Burden of Disease (GBD) 2023 estimates, we analyzed PCOS prevalence, incidence, and disability-adjusted life-years (DALYs) among individuals aged 10-54 years across 131 countries, stratified by Gross National Income (GNI) into low-income (LCs), lower-middle-income (LMCs), and upper-middle-income (UMCs) groups. Temporal trends were assessed using relative percentage change and the estimated annual percentage change (EAPC). Pearson correlation analyses evaluated the associations between GNI per capita and PCOS burden. Cross-country inequality and decomposition analyses were performed, and future burden was projected to 2050. All estimates are presented with 95% uncertainty intervals (UI).
resultsPCOS cases in LMICs accounted for 71.33% of the global total. PCOS-related DALYs showed a positive correlation with economic income levels, as measured by GNI per capita (R = 0.328, 95% CI 0.16-0.477, p < 0.001). Within LMICs, upper-middle-income countries experienced the highest contribution from epidemiological changes (82.46%), with population aging partially offsetting the overall increase in disease burden. In contrast, low-income countries, largely concentrated in Africa, experienced a sharp increase in PCOS incidence primarily driven by population growth. Although the peak age of onset (10-19 years) was uniform across LMICs, the decline in incidence began after age 25 in low-income countries but only after age 50 in both lower-middle-income and upper-middle-income countries. Projections to 2050 indicate an overall declining trend in PCOS burden for LMICs as a whole, yet lower-middle-income countries alone are projected to exhibit a contrasting upward trend.
conclusionsFrom 1990 to 2023, the prevalence, incidence, and DALYs of PCOS in LMICs increased significantly. Socioeconomic factors showed significant associations with PCOS epidemiology, though substantial variance remains unexplained.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.